Physician profile
Robert S Bader
NPI 1386862415
$1,347.01
in general payments reported to CMS, 2019-2025
20 companies · $500 in 2025
The $500 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46.79 · 2020: $147 · 2021: $11.12 · 2022: $96.04 · 2023: $96.51 · 2024: $449 · 2025: $500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,046.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,046.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $223.92 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Allergan, INC. | $147.05 | 2020 | |
| Genzyme Corporation | $116.32 | 2023-2025 | |
| Ucb, INC. | $88.07 | 2023-2025 | Bimzelx |
| Janssen Biotech, INC. | $83.33 | 2023-2025 | Tremfya |
| Merz North America, INC. | $83.26 | 2025 | |
| Abbvie INC. | $80.38 | 2024-2025 | |
| Lilly USA, LLC | $77.52 | 2024 | Taltz, Olumiant, Ebglyss |
| Strata Skin Sciences, INC. | $72.31 | 2021-2025 | Xtrac |
| Pfizer INC. | $56.92 | 2022-2023 | |
| Organon LLC | $49.28 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.02 | 2025 | Spevigo |
| Genentech USA, INC. | $46.79 | 2019 | |
| Galderma Laboratories, L.P. | $31.34 | 2022-2024 | Dysport |
| Novartis Pharmaceuticals Corporation | $30.32 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $27.66 | 2025 | Dupixent |
| E.R. Squibb & Sons, L.L.C. | $24.31 | 2024 | Sotyktu |
| Sun Pharmaceutical Industries INC. | $22.74 | 2025 | |
| Journey Medical Corporation | $19.65 | 2022 | |
| Amgen INC. | $18.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Bader listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.